Cubist Pharmaceuticals, Inc. (NASDAQ:CBST)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment.

Recs

0
Player Avatar pchop123 (71.80) Submitted: 2/6/2012 4:01:45 PM : Outperform Start Price: $42.30 CBST Score: -3.14

Must own in pharma area and possible takeover

Featured Broker Partners


Advertisement